SYNT — Syntheticmr publ AB Share News
0.000.00%
- SEK53.24m
- SEK25.04m
- SEK57.05m
Brief: SyntheticMR Q1 Operating Loss At SEK 0.8 Mln
Brief: SyntheticMR AB: Mayo Clinic Orders Syntheticmr's Solution For Clinical Routine
Brief: SyntheticMR Signs Collaboration Deal With Mahajan Imaging
Brief: SyntheticMR Q4 Operating Result Swings To Loss Of SEK 4.6 Mln
Brief: SyntheticMR CFO Fredrik Jeppsson Resigns
Brief: SyntheticMR Q3 Operating Profit Down At SEK 3.4 Mln
Brief: SyntheticMR: Yvonne Mårtensson Steps Down As Chairman
Brief: The Board Of Directors Has Decided To Postpone The Application For Changing Trading List To Nasdaq Omx
Brief: SyntheticMR Gets FDA Clearance For Use Of SyMRI On MRI Systems
Brief: SyntheticMR Q1 Operating Profit Down At SEK 2.9 Mln
Brief: Ulrik Harrysson Appointed New CEO Of SyntheticMR
Brief: Syntheticmr Q4 Operating Profit Unchanged At SEK 5.4 Million
Brief: SyntheticMR Q3 Operating Profit Up At SEK 5.4 Million
Brief: SyntheticMR CEO Stefan Tell To Leaves Company
Brief: Syntheticmr Q2 Operating Profit Rises To SEK 4.4 Million
Brief: SyntheticMR Gains Further Clearance From FDA For Its Software SyMRI
Brief: SyntheticMR Begins Process To Be Listed On NASDAQ OMX
Brief: SyntheticMR Q1 Operating Profit Slightly Up At SEK 3.6 Million
Brief: SyntheticMR Q4 Net Profit At SEK 3.9 Million